A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

CompletedOBSERVATIONAL

Enrollment

419

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions

Glaucoma, Open-AngleOcular Hypertension

Interventions

DRUG

bimatoprost 0.01% ophthalmic solution

Bimatoprost 0.01% ophthalmic solution (Lumigan® 0.01%) as prescribed by physician per standard practice for up to 14 weeks.

Trial Locations (1)

Vienna